Adverse Drug Reaction News Bulletins

ADR News Bulletin 2024 December (Volume 26 Number 3)

30 December 2024

Audiences

Healthcare professional

Industry member

Product-type

Therapeutic Products

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

Bulletin Highlights:

Potential risk of psychiatric withdrawal events with domperidone for stimulation of lactation
Overview of serious adverse event reports associated with programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) immune checkpoint inhibitors
Biosimilars evaluation: Update on HSA’s regulatory considerations for clinical comparability studies
AE Case in Focus: Test Yourself - What could have contributed to the patient's euglycaemic diabetic ketoacidosis (eDKA)?

Click on the link below to download the issue in pdf: